HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Nakaraang pagsara
$1.26
Sakop ng araw
$1.24 - $1.31
Sakop ng taon
$0.87 - $3.07
Market cap
38.53M USD
Average na Volume
88.78K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
AP News
1 oras ang nakalipas
US stocks drop as Nvidia slides and the fog of Trump’s trade war thickens
6.87%
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 8.61M | -54.25% |
Net na kita | -7.52M | 55.49% |
Net profit margin | — | — |
Kita sa bawat share | -0.25 | 55.79% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 83.62M | -22.07% |
Kabuuang asset | 92.09M | -33.63% |
Kabuuang sagutin | 10.24M | -27.10% |
Kabuuang equity | 81.85M | — |
Natitirang share | 30.10M | — |
Presyo para makapag-book | 0.46 | — |
Return on assets | -22.68% | — |
Return on capital | -25.39% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -7.52M | 55.49% |
Cash mula sa mga operasyon | -5.27M | 69.11% |
Cash mula sa pag-invest | -6.88M | -1,738.10% |
Cash mula sa financing | 0.00 | 100.00% |
Net change in cash | -12.15M | 28.38% |
Malayang cash flow | -1.76M | 83.92% |
Tungkol
Itinatag
2017
Headquarters
Website
Mga Empleyado
22
